Experienced in Common Variable Immune Deficiency

Dr. William J. Towner

Internal Medicine
4733 W Sunset Blvd, 
Los Angeles, CA 
Experienced in Common Variable Immune Deficiency
4733 W Sunset Blvd, 
Los Angeles, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

William Towner is a primary care provider, practicing in Internal Medicine in Los Angeles, California. Dr. Towner is rated as an Experienced provider by MediFind in the treatment of Common Variable Immune Deficiency. His top areas of expertise are HIV/AIDS, Hepatitis, Hepatitis C, and Hepatitis B.

His clinical research consists of co-authoring 69 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Common Variable Immune Deficiency.

Specialties
Internal Medicine
Licenses
Internal Medicine in CA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID

Locations

4733 W Sunset Blvd, Los Angeles, CA 90027

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 2a Multicentre, Randomized, Open-Label, Two-Part Adaptive Design Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A, an HIV-1 Specific Broadly Neutralizing Human Monoclonal Antibody in Antiretroviral-naïve HIV-1-Infected Adults
A Phase 2a Multicentre, Randomized, Open-Label, Two-Part Adaptive Design Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A, an HIV-1 Specific Broadly Neutralizing Human Monoclonal Antibody in Antiretroviral-naïve HIV-1-Infected Adults
Enrollment Status: Completed
Publish Date: October 15, 2024
Intervention Type: Biological
Study Drug: GSK3810109A
Study Phase: Phase 2
A Phase IIb, Randomized, Partially Blind, Active Controlled, Dose-range Finding Study of GSK3640254 Compared to a Reference Arm of Dolutegravir, Each in Combination With Nucleoside Reverse Transcriptase Inhibitors, in HIV-1 Infected Antiretroviral Treatment-naive Adults
A Phase IIb, Randomized, Partially Blind, Active Controlled, Dose-range Finding Study of GSK3640254 Compared to a Reference Arm of Dolutegravir, Each in Combination With Nucleoside Reverse Transcriptase Inhibitors, in HIV-1 Infected Antiretroviral Treatment-naive Adults
Enrollment Status: Terminated
Publish Date: June 26, 2024
Intervention Type: Drug
Study Drugs: GSK3640254, ABC/3TC, FTC/TAF, Dolutegravir
Study Phase: Phase 2
A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine Administered Every Two Months From a Bictegravir/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: June 04, 2024
Intervention Type: Drug
Study Drugs: Cabotegravir, Rilpivirine, BIKTARVY
Study Phase: Phase 3
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: July 19, 2023
Intervention Type: Drug
Study Drugs: Dolutegravir+Lamivudine, Tenofovir alafenamide based regimen
Study Phase: Phase 3
A Phase 3, Multicenter, Expanded Access Study of Ibalizumab Plus an Optimized Background Regimen (OBR) in Treatment-Experienced Patients Infected With Multi-Drug Resistant (MDR) HIV-1
A Phase 3, Multicenter, Expanded Access Study of Ibalizumab Plus an Optimized Background Regimen (OBR) in Treatment-Experienced Patients Infected With Multi-Drug Resistant (MDR) HIV-1
Enrollment Status: Completed
Publish Date: March 11, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

69 Total Publications

Immunogenicity and Safety of the Bivalent Respiratory Syncytial Virus Prefusion F Subunit Vaccine in Immunocompromised or Renally Impaired Adults.
Immunogenicity and Safety of the Bivalent Respiratory Syncytial Virus Prefusion F Subunit Vaccine in Immunocompromised or Renally Impaired Adults.
Journal: Vaccines
Published: January 14, 2025
Similar Doctors
Advanced in Common Variable Immune Deficiency
Dr. Bruce S. Gillis
Internal Medicine
Advanced in Common Variable Immune Deficiency
Dr. Bruce S. Gillis
Internal Medicine
11801 W Olympic Blvd, 
Los Angeles, CA 
 (10.0 miles away)
310-268-1001
Languages Spoken:
English
See accepted insurances

Bruce Gillis is a primary care provider, practicing in Internal Medicine in Los Angeles, California. Dr. Gillis is rated as an Advanced provider by MediFind in the treatment of Common Variable Immune Deficiency. His top areas of expertise are Common Variable Immune Deficiency, Primary Immunodeficiency (PID), and Fibromyalgia.

Advanced in Common Variable Immune Deficiency
Dr. Homan Siman
Internal Medicine
Advanced in Common Variable Immune Deficiency
Dr. Homan Siman
Internal Medicine

Complete Care Family Medical Clinic

1231 N Avalon Blvd, 
Wilmington, CA 
 (21.5 miles away)
310-835-7215
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Homan Siman is a primary care provider, practicing in Internal Medicine in Wilmington, California. Dr. Siman is rated as an Advanced provider by MediFind in the treatment of Common Variable Immune Deficiency. His top areas of expertise are Methylmalonic Acidemia with Homocystinuria, Homocystinuria, Inborn Amino Acid Metabolism Disorder, and Cirrhosis.

Experienced in Common Variable Immune Deficiency
Dr. Andrew Q. Pham
Internal Medicine
Experienced in Common Variable Immune Deficiency
Dr. Andrew Q. Pham
Internal Medicine

Southern California Permanente Medical Group

6041 Cadillac Ave, 
Los Angeles, CA 
 (6.3 miles away)
800-954-8000
Experience:
17+ years
Languages Spoken:
English
See accepted insurances

Andrew Pham is a primary care provider, practicing in Internal Medicine in Los Angeles, California. Dr. Pham has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Common Variable Immune Deficiency. His top areas of expertise are Chronic Spontaneous Urticaria (CSU), Vibratory Urticaria, Nonallergic Rhinopathy, and Hives.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Towner's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile